Catalyst Pharmaceuticals, Inc. (CPRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4800+0.0400 (+1.16%)
At close: 4:00PM EST
3.4700 -0.01 (-0.29%)
After hours: 4:23PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 3.4400 |
| Open | 3.4900 |
| Bid | 3.4500 x 1000 |
| Ask | 3.5000 x 3100 |
| Day's Range | 3.4000 - 3.5400 |
| 52 Week Range | 2.5500 - 5.2800 |
| Volume | 1,965,223 |
| Avg. Volume | 1,530,416 |
| Market Cap | 360.695M |
| Beta (5Y Monthly) | 1.54 |
| PE Ratio (TTM) | 5.19 |
| EPS (TTM) | 0.6700 |
| Earnings Date | Nov 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.40 |
- Simply Wall St.
What You Need To Know About The Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Analyst Downgrade Today
The latest analyst coverage could presage a bad day for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), with the...
- Simply Wall St.
Results: Catalyst Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
As you might know, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) recently reported its third-quarter numbers. Revenues...
- Zacks
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings Estimates
Catalyst (CPRX) delivered earnings and revenue surprises of 22.22% and -6.10%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
© 2020 Verizon Media. All rights reserved.
